To evaluate the efficacy of Z-338 [acotiamide] in subjects with functional dyspepsia, focusing on the assessment of subjective symptoms

Trial Profile

To evaluate the efficacy of Z-338 [acotiamide] in subjects with functional dyspepsia, focusing on the assessment of subjective symptoms

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Jun 2016

At a glance

  • Drugs Acotiamide (Primary)
  • Indications Non-ulcer dyspepsia
  • Focus Therapeutic Use
  • Sponsors Zeria
  • Most Recent Events

    • 26 Apr 2008 Status changed from in progress to completed.
    • 01 Dec 2006 Status change
    • 29 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top